• Company
• Kwangdong will sell GSK’s allergic rhinitis treatment
• by Chon, Seung-Hyun Jun 28, 2022 06:09am

• Policy
• Fenofibrate regardless of meals will be listed next month
• by Lee, Tak-Sun Jun 28, 2022 06:09am

• Company
• Oral SMA drug Evrysdi may be prescribed at general hospitals
• by Eo, Yun-Ho Jun 27, 2022 05:58am

• Policy
• The use of Benzalconium chloride is not interrupted
• by Lee, Hye-Kyung Jun 27, 2022 05:58am

• Company
• This time it’s acyclovir… impurity issue rises again
• by Chon, Seung-Hyun Jun 27, 2022 05:57am

• Company
• Belvarafenib confirmed its safety & effectiveness
• by Chon, Seung-Hyun Jun 27, 2022 05:57am

• Company
• The flu is going around in the southern hemisphere
• by Whang, byung-woo Jun 27, 2022 05:57am

• Policy
• Is "Platform of Drug Delivery" starting?
• by Lee, Jeong-Hwan Jun 24, 2022 05:46am

• Company
• Sanofi’s Allegra dominates OTC·ETC drug market
• by Nho, Byung Chul Jun 24, 2022 05:46am

• Company
• Yuhan’s new lung cancer drug Leclaza shows OS benefit
• by Nho, Byung Chul Jun 24, 2022 05:46am